Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_assertion type Assertion NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_head.
- NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_assertion description "[All available Swedish isolates from 1998-2009, collected from many countries worldwide, displaying decreased susceptibility to cefixime and/or ceftriaxone (minimum inhibitory concentration (MIC) ? 0.032 mg/l; n=331) were examined using antibiograms, full-length porB gene sequencing, N gonorrhoeae multi-antigen sequence typing (NG-MAST), and sequencing of ESC resistance determinants (penA, mtrR and porB1b (penB alteration)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_provenance.
- NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_assertion evidence source_evidence_literature NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_provenance.
- NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_assertion SIO_000772 20940159 NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_provenance.
- NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_assertion wasDerivedFrom befree-20140225 NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_provenance.
- NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_assertion wasGeneratedBy ECO_0000203 NP833442.RACtDIGnE8xG_7gCvcrJX9aFPpTPyMwH4tQRV2LHqIgQQ130_provenance.